Letters
Long acting β2 agonists in adult asthma
Authors’ reply to Hasford
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6599 (Published 06 November 2013) Cite this as: BMJ 2013;347:f6599
- Graeme P Currie, consultant chest physician1,
- Graham Douglas, consultant physician1
- 1Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK
- Graeme.currie{at}nhs.net
We thank Hasford for his comments on our article,1 2 particularly those relating to the Salmeterol Multicenter Asthma Research Trial (SMART).3 However, the trial found that the occurrence of the primary outcome (respiratory related deaths or life threatening …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.